Modification of the existing maximum residue levels for clopyralid in various commodities.
MRL
animal commodities
clopyralid
consumer risk assessment
herbicide
oat
wheat
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
2
2
2021
Statut:
epublish
Résumé
In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Corteva submitted a request to the competent national authority in Finland to modify the existing maximum residue levels (MRLs) for the active substance clopyralid in various commodities. The data submitted in support of the request were found to be sufficient to derive MRL proposals for wheat, oat and for animal commodities. An adequate analytical method for enforcement is available to control the residues of clopyralid in the plant commodities under consideration at the validated limit of quantification (LOQ) of 0.01 mg/kg. The analytical methods for animal commodities are validated at LOQ of 0.01 mg/kg, but demonstration of extraction efficiency is lacking. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the use of clopyralid according to the reported agricultural practices is unlikely to present a risk to consumer health provided that risk mitigation measures are in place to avoid clopyralid residues in rotational and/or succeeding crops.
Identifiants
pubmed: 33519993
doi: 10.2903/j.efsa.2021.6389
pii: EFS26389
pmc: PMC7821602
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e06389Informations de copyright
© 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Références
EFSA J. 2018 Jan 15;16(1):e05147
pubmed: 32625691
EFSA J. 2018 Jan 29;16(1):e05149
pubmed: 32625693
EFSA J. 2018 Aug 03;16(8):e05389
pubmed: 32626025
EFSA J. 2021 Jan 11;19(1):e06376
pubmed: 33456554